Cynomolgus IL-18BP Protein (IL8-CM1BP)
$283.50 – $945.00
KACTUS Biosystems Cynomolgus IL-18BP Protein (IL8-CM1BP) (catalog No. IL8-CM1BP) is expressed from HEK293 with His tag at the C-Terminus.It contains Thr28-Pro207.
- Product Details
- Description
- Additional information
- More Offers
| Catalog No. | IL8-CM1BP |
|---|---|
| Product Name | Cynomolgus IL-18BP Protein (IL8-CM1BP) |
| Supplier Name | KACTUS Biosystems |
| Brand Name | KACTUS Biosystems |
| Species | Cynomolgus |
| Source | HEK293 |
| Accession | A0A2K5UDJ4 |
| Product Tag | C-His |
| Biotinylated | no |
| Exact Sequence | Thr28-Pro207 |
| Molecular Weight | The protein has a predicted MW of 21.14 kDa. Due to glycosylation, the protein migrates to 35-65 kDa based on Tris-Bis PAGE result. |
| Form | Lyophilized |
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
| Endotoxin | Less than 1EU per μg by the LAL method. |
| Shipping | Shipped at ambient temperature. |
| Stability & Storage | '-20 to -80°C for 12 months as supplied from date of receipt.；-20 to -80°C for 3-6 months in unopened state after reconstitution.；2-8°C for 2-7 days after reconstitution.；Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
| Note | Products will be shipped from the warehouse in Massachusetts. Promotion is running from time to time. Welcome to send a request for quote to message@sydlabs.com. |
| Order Offline | Syd Labs, Inc. 4 Avenue E, Hopkinton, MA 01748 USA. Phone: 1-617-401-8149 Fax: 1-617-606-5019 Email: message@sydlabs.com |
Description
IL8-CM1BP: Cynomolgus IL-18BP Protein (IL8-CM1BP)
Cytokines were the first modern immunotherapies to produce durable responses in patients with advanced cancer,components of the interleukin-18 (IL-18) pathway are upregulated on tumour-infiltrating lymphocytes, suggesting that IL-18 therapy could enhance anti-tumour immunity. IL-18BP, a high-affinity IL-18 decoy receptor, is frequently upregulated in diverse human and mouse tumours and limits the anti-tumour activity of IL-18 in mice.
Please remember our product information: Cynomolgus IL-18BP Protein (IL8-CM1BP) catalog number: IL8-CM1BP KACTUS Biosystems
Additional information
| Ship from Country | USA |
|---|---|
| Size | 100 ug, 500 ug |